US stocks surge to record highs
The S&P 500 notched up eight straight record closes in a row recently, while the small-cap Russell 2000 index saw its first record close since March.

Central banks may have made bond markets wobble, but stocks are still going from strength to strength, says Nicholas Megaw in the Financial Times. Strong US third-quarter earnings have put worries about inflation on the back burner. Profits at S&P 500 firms rose by about 40% year-on-year between July and September. Sales increased by roughly a fifth.
“Large US companies are broadly managing to weather the surge in the prices of raw materials, supply chain bottlenecks and shortages in the labour market,” say Joe Rennison and Colby Smith in the same paper. Corporate profit margins have fallen back slightly, but by much less than analysts had been expecting.
Major US stock benchmarks continue to make new record highs, says Mark DeCambre on MarketWatch. The S&P 500 notched up eight straight record closes through Monday this week, its longest streak of all-time peaks since 1997. Smaller companies have also joined the party: the small-cap Russell 2000 index has just had its first record close since March.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
“It doesn’t get any better than this for the stockmarket,” says Ben Levisohn in Barron’s. A “stellar” jobs report – the US economy added 531,000 jobs last month – only adds to a picture of an American economy regaining its vigour after a sluggish summer. There is growing hope that new antiviral treatments from Merck and Pfizer will soon draw a line under the pandemic era.
To top it all, Congress has finally approved a $1.2trn infrastructure bill after months of wrangling. Equities fell by 5% in September, sparking talk of a correction (defined as a stockmarket decline of 10%). Instead, equities have since rallied by 7%. Is that a reason to sell? With the bulls out in force, probably not. “Bet on a rip-roaring rally into the end of the year.”
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
ISA reforms on the horizon, but will cash savers lose out?
Cash ISAs are safe for now from any cuts, but the push for investing in stocks and shares is almost certainly coming and could be announced in the Autumn Budget
By Kalpana Fitzpatrick Published
-
Top investment scams to beware of
Fraudsters are finding ever more sophisticated ways of stealing your hard-earned money. Before parting with a penny, read our guide on the top investment scams and how to avoid them
By Samantha Partington Published
-
Is the US economy set for success?
Ignore the pessimists: US stocks will keep charging ahead, says Max King
By Max King Published
-
UnitedHealth shares slump — is the US healthcare industry in trouble?
The murder of UnitedHealthcare’s CEO has shone a spotlight on a struggling US healthcare industry with an inauspicious outlook
By Dr Matthew Partridge Published
-
Are US stocks too expensive?
US stocks have rallied since Donald Trump's election win, but starting valuations are so high that analysts forecast weak performance over the next decade
By Alex Rankine Published
-
Should you bet on US stocks?
You don’t have to be bearish on US stocks to worry that they are now such a large share of global indices
By Cris Sholto Heaton Published
-
Wall Street enjoys a Trump sugar rush – will it crash?
Wall Street investors could be repeating the mistakes they made in Trump's first term, when “Trump trades” enjoyed a short pop and then underperformed
By Alex Rankine Published
-
United Airlines set for growth – should you invest?
Airlines have rebounded well after Covid, but United Airlines can soar higher
By Dr Matthew Partridge Published
-
What will a broken-up Google look like?
The US courts have ruled that Google is a monopoly, leaving it facing the prospect of a break-up. WIll that be a good thing?
By Matthew Lynn Published
-
Who is John Donahoe, the man who made Nike uncool?
Nike’s 48-year success story has been put into question by John Donahoe, its outgoing CEO who knew nothing about Nike or its culture. What mistakes did he make?
By Jane Lewis Published